29 results
8-K
EX-10.1
COYA
Coya Therapeutics Inc
20 May 24
Coya Therapeutics Announces $5 Million Strategic
5:00pm
. The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks as the Company
424B3
tluc 3slx310ckf
16 Jan 24
Prospectus supplement
4:06pm
S-3
6m50u39
4 Jan 24
Shelf registration
4:46pm
8-K
mwmw8yy
6 Dec 23
Entry into a Material Definitive Agreement
7:30am
8-K
EX-99.1
kp8cn8e5a6o87bo0e
6 Dec 23
Entry into a Material Definitive Agreement
7:30am
8-K
EX-10.1
lef4zark6p3xhsp3w
6 Dec 23
Entry into a Material Definitive Agreement
7:30am
DEF 14A
w775pogvl3a8rdeo62w5
19 May 23
Definitive proxy
4:31pm
10-Q
EX-10.1
35r0bjb
10 May 23
Quarterly report
7:14am
10-K
w3dkcksf v62op
29 Mar 23
Annual report
4:08pm
424B4
kplzox12ghac 4qkoug
30 Dec 22
Prospectus supplement with pricing info
4:17pm
S-1/A
EX-10.12
nbt0pvm8 mno92pd6bq
5 Dec 22
IPO registration (amended)
8:16am
S-1/A
24emqymvrehzvxi7iasq
5 Dec 22
IPO registration (amended)
8:16am